아지 바이오파마 보도자료 보도자료 December 18, 2018 Ajinomoto and XL-protein forge Strategic Alliance to develop PASylated therapeutics applying the CORYNEX® platform 더 읽어보기 November 28, 2018 Ajinomoto Bio-Pharma Services Introduces AJICAP Bioconjugation Technology for ADC Manufacturing 더 읽어보기 October 23, 2018 Precision NanoSystems Announces Manufacturing Collaboration Agreement with Ajinomoto Bio-Pharma Services for GMP Manufacturing of High Quality Nanomedicines 더 읽어보기 October 2, 2018 Ajinomoto Althea and OmniChem Combine to Form Ajinomoto Bio-Pharma Services, Reflecting a Collective Range of Services Offered to the Bio-Pharma Industry 더 읽어보기 April 14, 2017 Ajinomoto OmniChem Launches Flow Chemistry for API Commercial Manufacturing 더 읽어보기 April 13, 2017 Ajinomoto OmniChem Launches Flow Chemistry for API Commercial Manufacturing 더 읽어보기 December 18, 2016 Ajinomoto Group Acquires All Shares of GeneDesign, a Nucleic Acid Drug CDMO, to Accelerate Expansion of the Contract Business for Oligonucleotides. 더 읽어보기
